ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 356 filers reported holding ASTRAZENECA PLC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $268,000 | -75.8% | 7,912 | -80.5% | 0.02% | +400.0% |
| Q4 2016 | $1,107,000 | -13.9% | 40,533 | +3.6% | 0.01% | -16.7% |
| Q3 2016 | $1,285,000 | +299.1% | 39,118 | +241.9% | 0.01% | +200.0% |
| Q1 2016 | $322,000 | -86.5% | 11,441 | -83.7% | 0.00% | -83.3% |
| Q4 2015 | $2,390,000 | +80.9% | 70,392 | +69.6% | 0.01% | +140.0% |
| Q3 2015 | $1,321,000 | -57.1% | 41,513 | -14.2% | 0.01% | -64.3% |
| Q2 2015 | $3,082,000 | +1251.8% | 48,379 | +1355.0% | 0.01% | +1300.0% |
| Q1 2015 | $228,000 | -93.9% | 3,325 | -93.8% | 0.00% | -93.3% |
| Q4 2014 | $3,761,000 | +188.2% | 53,441 | +192.5% | 0.02% | +200.0% |
| Q3 2014 | $1,305,000 | -79.4% | 18,270 | -78.5% | 0.01% | -82.8% |
| Q2 2014 | $6,320,000 | +1270.9% | 85,054 | +1096.1% | 0.03% | +1350.0% |
| Q1 2014 | $461,000 | -91.8% | 7,111 | -92.5% | 0.00% | -90.0% |
| Q4 2013 | $5,610,000 | +160.6% | 94,485 | +127.9% | 0.02% | +150.0% |
| Q3 2013 | $2,153,000 | – | 41,452 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |